11.11.2009 • News

Bayer Cropscience Buys U.S. Biotech Company Athenix

Bayer Cropscience announced that it has entered into an agreement to purchase Athenix, a privately-held independent biotechnology company. The acquisition of Athenix and its innovative technology platform will boost Bayer Cropscience's ability to make available novel technology and complete agricultural solutions to growers worldwide. The acquisition is subject to premerger notification. The final purchase price is yet to be disclosed.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read